These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 27177826)
1. Synergistic potentiation of (-)-lomaiviticin A cytotoxicity by the ATR inhibitor VE-821. Colis LC; Herzon SB Bioorg Med Chem Lett; 2016 Jul; 26(13):3122-3126. PubMed ID: 27177826 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of action studies of lomaiviticin A and the monomeric lomaiviticin aglycon. Selective and potent activity toward DNA double-strand break repair-deficient cell lines. Colis LC; Hegan DC; Kaneko M; Glazer PM; Herzon SB J Am Chem Soc; 2015 May; 137(17):5741-7. PubMed ID: 25849366 [TBL] [Abstract][Full Text] [Related]
3. The Mechanism of Action of (-)-Lomaiviticin A. Herzon SB Acc Chem Res; 2017 Oct; 50(10):2577-2588. PubMed ID: 28956437 [TBL] [Abstract][Full Text] [Related]
4. Sulfoximines as ATR inhibitors: Analogs of VE-821. Hendriks CMM; Hartkamp J; Wiezorek S; Steinkamp AD; Rossetti G; Lüscher B; Bolm C Bioorg Med Chem Lett; 2017 Jun; 27(12):2659-2662. PubMed ID: 28479198 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of (2 Kaneko M; Li Z; Burk M; Colis L; Herzon SB J Am Chem Soc; 2021 Jan; 143(2):1126-1132. PubMed ID: 33410680 [TBL] [Abstract][Full Text] [Related]
6. The cytotoxicity of (-)-lomaiviticin A arises from induction of double-strand breaks in DNA. Colis LC; Woo CM; Hegan DC; Li Z; Glazer PM; Herzon SB Nat Chem; 2014 Jun; 6(6):504-10. PubMed ID: 24848236 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related ( Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998 [TBL] [Abstract][Full Text] [Related]
8. VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation. Fujisawa H; Nakajima NI; Sunada S; Lee Y; Hirakawa H; Yajima H; Fujimori A; Uesaka M; Okayasu R Radiat Oncol; 2015 Aug; 10():175. PubMed ID: 26286029 [TBL] [Abstract][Full Text] [Related]
9. ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage. Song N; Jing W; Li C; Bai M; Cheng Y; Li H; Hou K; Li Y; Wang K; Li Z; Liu Y; Qu X; Che X Cell Cycle; 2018; 17(5):595-604. PubMed ID: 29157079 [TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of Ataxia Telangiectasia and Rad3 related kinase (ATR) sensitize lymphoma cells to UVA radiation. Biskup E; Naym DG; Gniadecki R J Dermatol Sci; 2016 Dec; 84(3):239-247. PubMed ID: 27743911 [TBL] [Abstract][Full Text] [Related]
11. The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. Moolmuang B; Ruchirawat M J Pharm Pharmacol; 2021 Mar; 73(1):40-51. PubMed ID: 33791808 [TBL] [Abstract][Full Text] [Related]
12. Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition. Middleton FK; Patterson MJ; Elstob CJ; Fordham S; Herriott A; Wade MA; McCormick A; Edmondson R; May FE; Allan JM; Pollard JR; Curtin NJ Oncotarget; 2015 Oct; 6(32):32396-409. PubMed ID: 26486089 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis. Šalovská B; Fabrik I; Ďurišová K; Link M; Vávrová J; Řezáčová M; Tichý A Int J Mol Sci; 2014 Jul; 15(7):12007-26. PubMed ID: 25003641 [TBL] [Abstract][Full Text] [Related]
14. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Reaper PM; Griffiths MR; Long JM; Charrier JD; Maccormick S; Charlton PA; Golec JM; Pollard JR Nat Chem Biol; 2011 Apr; 7(7):428-30. PubMed ID: 21490603 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis. Qi W; Xu X; Wang M; Li X; Wang C; Sun L; Zhao D; Sun L Biochem Pharmacol; 2019 Jun; 164():273-282. PubMed ID: 31014753 [TBL] [Abstract][Full Text] [Related]
16. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma. Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208 [TBL] [Abstract][Full Text] [Related]
17. Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells. Šalovská B; Janečková H; Fabrik I; Karlíková R; Čecháková L; Ondrej M; Link M; Friedecký D; Tichý A PLoS One; 2018; 13(7):e0199349. PubMed ID: 30001349 [TBL] [Abstract][Full Text] [Related]
18. [Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells]. Yang Z; Sun C; Liu Y; Gong C; Chen G; Weng D Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):805-10. PubMed ID: 25620475 [TBL] [Abstract][Full Text] [Related]